Loomis Sayles & Co. L P Invests $38,000 in National Health Investors, Inc. (NYSE:NHI)

Loomis Sayles & Co. L P purchased a new stake in shares of National Health Investors, Inc. (NYSE:NHI) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 450 shares of the real estate investment trust’s stock, valued at approximately $38,000.

A number of other large investors have also added to or reduced their stakes in the stock. Strategic Financial Concepts LLC bought a new position in shares of National Health Investors during the 2nd quarter valued at approximately $28,000. Covestor Ltd raised its holdings in shares of National Health Investors by 2,700.0% in the 3rd quarter. Covestor Ltd now owns 420 shares of the real estate investment trust’s stock worth $35,000 after purchasing an additional 405 shares during the period. International Assets Investment Management LLC purchased a new position in National Health Investors in the second quarter valued at approximately $36,000. Blue Trust Inc. grew its holdings in National Health Investors by 2,651.9% during the second quarter. Blue Trust Inc. now owns 743 shares of the real estate investment trust’s stock valued at $47,000 after purchasing an additional 716 shares during the period. Finally, Assetmark Inc. increased its position in National Health Investors by 27.8% in the third quarter. Assetmark Inc. now owns 648 shares of the real estate investment trust’s stock worth $54,000 after buying an additional 141 shares during the last quarter. Hedge funds and other institutional investors own 62.51% of the company’s stock.

National Health Investors Price Performance

Shares of NYSE:NHI opened at $76.91 on Friday. The company has a 50 day moving average of $79.01 and a 200 day moving average of $74.68. The company has a current ratio of 10.29, a quick ratio of 10.29 and a debt-to-equity ratio of 0.92. The stock has a market cap of $3.49 billion, a P/E ratio of 26.43, a P/E/G ratio of 5.14 and a beta of 1.05. National Health Investors, Inc. has a 12 month low of $51.59 and a 12 month high of $86.13.

National Health Investors (NYSE:NHI) last released its quarterly earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 earnings per share for the quarter, missing the consensus estimate of $1.07 by ($0.42). National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. The firm had revenue of $63.32 million during the quarter, compared to the consensus estimate of $67.93 million. During the same period in the previous year, the company posted $1.08 EPS. The company’s revenue for the quarter was up 1.7% compared to the same quarter last year. As a group, sell-side analysts forecast that National Health Investors, Inc. will post 4.42 EPS for the current fiscal year.

National Health Investors Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 29th. Shareholders of record on Tuesday, December 31st will be issued a $0.90 dividend. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.60 annualized dividend and a dividend yield of 4.68%. National Health Investors’s payout ratio is currently 123.71%.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the company. StockNews.com downgraded National Health Investors from a “buy” rating to a “hold” rating in a research note on Tuesday, October 15th. Truist Financial increased their target price on shares of National Health Investors from $65.00 to $78.00 and gave the stock a “hold” rating in a research report on Friday, August 30th. Wells Fargo & Company lowered shares of National Health Investors from an “overweight” rating to an “equal weight” rating and boosted their price target for the company from $81.00 to $86.00 in a research report on Tuesday, October 1st. Finally, Bank of America initiated coverage on shares of National Health Investors in a report on Tuesday, September 24th. They issued a “buy” rating and a $92.00 price objective for the company. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $76.33.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.